We are live on
!
Find out more
ABMD
Abiomed Inc
ABMD
ABMD
Delisted
ABMD was delisted on the 21st of December, 2022.
500 hedge funds and large institutions have $13.8B invested in Abiomed Inc in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 173 increasing their positions, 182 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
47% more call options, than puts
Call options by funds: $49.4M | Put options by funds: $33.7M
18% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 51
1% more funds holding
Funds holding: 496 → 500 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 182
8% less capital invested
Capital invested by funds: $15.1B → $13.8B (-$1.22B)
Holders
500
Holders Change
+4
Holders Change %
+0.81%
% of All Funds
7.89%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
60
Increased
173
Reduced
182
Closed
51
Calls
$49.4M
Puts
$33.7M
Net Calls
+$15.7M
Net Calls Change
+$7.94M
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$170M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$166M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$65M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$51.5M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$40.2M |
